DASFREE: An 18-month update of dasatinib discontinuation in patients with chronic myeloid leukemia in chronic phase and deep molecular response Meeting Abstract


Authors: Shah, N. P.; García-Gutiérrez, V.; Jiménez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casare, M. T.; Pane, F.; Nicolini, F. E.; Mauro, M. J.; Sy, O.; Martin-Regueira, P.; Lipton, J. H.
Abstract Title: DASFREE: An 18-month update of dasatinib discontinuation in patients with chronic myeloid leukemia in chronic phase and deep molecular response
Meeting Title: 59th Annual Scientific Meeting of the British Society for Hematology
Keywords: dasatinib; chronic myeloid leukemia; treatment-free remission; tfr; tki discontinuation
Journal Title: British Journal of Haematology
Volume: 185
Issue: Suppl. 1
Meeting Dates: 2019 Apr 1-3
Meeting Location: Glasgow, UK
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2019-03-01
Start Page: 52
Language: English
ACCESSION: WOS:000462529200068
PROVIDER: wos
PUBMED: 30916380
DOI: 10.1111/bjh.15854
Notes: Meeting Abstract: BSH19-PO-029 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    267 Mauro